Fabrinet: Options Flip Bullish, Short Interest Climbs, MSCI Deletion Looms Before Sunday's Print

FN gained 9.8% over the past week to close at $348.68, outpacing a median 7.5% rise among its closest peers, yet the stock remains 15% lower than a month ago and has shed more than a fifth of its value since August's brutal earnings reaction.

The options market tells a notably different story from the short side. The put/call ratio has dropped to 0.64, roughly 1.5 standard deviations below its 20-day average of 0.71. That is the most call-heavy positioning in the past year, which in a stock down 15% over a month looks less like confident bottom-fishing and more like hedges expiring and some short-dated call buying as the print nears. Short interest, meanwhile, has continued to build: it rose 14% over the past week to 5.22% of the free float, adding to a 36% climb over the past month. The lending market remains frictionless on the other side. Availability has eased to 8,676%, well above even the 52-week trough of 402%, and cost to borrow at 0.47% has nearly doubled over the week but is still cheap by any measure. Short sellers face no mechanical obstacle adding to positions before Sunday's release.

The analyst debate has narrowed to a single question: is this a quality franchise in a temporary air pocket, or is concentration risk finally being priced correctly? Needham cut its target from $650 to $500 on 27 October while holding a Buy, following Susquehanna's trim from $850 to $600 a week earlier. The pattern of maintained positive ratings but rapidly falling targets captures the bull case well: the company posted 45% revenue growth year-over-year to $1.316 billion last quarter, gross margin held at 12.2%, and management has outlined capacity for roughly $14 billion in annual revenue. Bears counter that four customers each contributed at least 10% of FY26 revenue, that NVIDIA-related revenue is expected to fall from $200 million to $125 million sequentially, and that order visibility runs to only about 13 weeks. With consensus targets still clustered well above the current price, the Street is arguing over the trajectory, not the direction.

One additional mechanical force arrives shortly after earnings. ORTEX puts the probability of FN being dropped from the MSCI World and several related large-cap indices at 97% in the November Quarterly Review, with an announcement expected 11 November and a trade date of 30 November. That deletion would force an estimated $938 million in index-tracker selling in the MSCI World alone, the equivalent of roughly 2.8 days of normal trading volume. Simultaneously, ORTEX forecasts a 97% chance of addition to the MSCI World Small and MSCI USA Small indices, which would bring an offsetting $934 million and $525 million in buying respectively. The net effect is mechanically uncertain and depends on which tracker types hold larger positions, but the sheer size of the flows relative to daily volume means the period around 30 November is as likely to drive price action as the earnings print itself.

After the last quarterly report in August, FN fell 15% on the day and 26% over the following five days, the sharpest single-quarter reaction in the recent record. Peer COHR gained 14.1% over the past week while TTMI rose 18.6%, both recovering faster than Fabrinet on a one-week basis. PLXS was the notable laggard, down 9.6% on the day. The November 2 print will test whether Q1 revenues confirm a new AI-driven baseline above $1.3 billion, or whether NVIDIA customer weakness and any miss on the datacom ramp validates the bear case that concentration risk is structural rather than transitional.